Abstract
A 308-nm XeCl excimer laser with a 225-ns pulse duration provides energy through fiber optics for ablation of obstructive atherosclerotic lesions. Initial clinical trials in 110 patients showed an 85% success rate with no deaths or perforations.
© 1990 Optical Society of America
PDF ArticleMore Like This
Warren S. Grundfest, Frank Litvack, Tsvi Goldenberg, Lynn Doyle, Tom Pacala, James Laudenslager, and James Forrester
FE1 International Laser Science Conference (ILS) 1986
Warren Grundfest, Frank Litvack, Tsvi Goldenberg, James Forrester, James B. Laudenslager, Thomas J. Pacala, and I. S. McDermid
TUA1 Conference on Lasers and Electro-Optics (CLEO:S&I) 1986
Qiushi Ren, Shuming Nie, Douglas C. B. Reed, Spencer B. King, and Nai-Teng Yu
CThF1 Conference on Lasers and Electro-Optics (CLEO:S&I) 1992